DFNA5 Antikörper
-
- Target Alle DFNA5 Antikörper anzeigen
- DFNA5 (Deafness, Autosomal Dominant 5 (DFNA5))
-
Reaktivität
- Human, Ratte, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser DFNA5 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Aufreinigung
- Immunogen affinity purified
- Reinheit
- ≥95 % as determined by SDS-PAGE
- Immunogen
- deafness, autosomal dominant 5
- Isotyp
- IgG
- Top Product
- Discover our top product DFNA5 Primärantikörper
-
-
- Applikationshinweise
- WB: 1:500 - 1:2000, IHC: 1:50 - 1:200
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3 ,
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
- Haltbarkeit
- 12 months
-
- Target
- DFNA5 (Deafness, Autosomal Dominant 5 (DFNA5))
- Andere Bezeichnung
- DFNA5 (DFNA5 Produkte)
- Hintergrund
- Synonyms:deafness, autosomal dominant 5, DFNA5, ICERE 1, ICERE1 Background:Hearing impairment is a heterogeneous condition with over 40 loci described. The protein encoded by this gene is expressed in fetal cochlea, however, its function is not known. Nonsyndromic hearing impairment is associated with a mutation in this gene. Three transcript variants encoding two different isoforms have been found for this gene.
- Molekulargewicht
- Refer to figures
- Gen-ID
- 1687
- UniProt
- O60443
- Pathways
- Sensory Perception of Sound
-